Clinical Trial Update: Detecting Infections Rapidly and Easily for Candidemia Trial (DIRECT)

View source ↗

Summary

The DIRECT trial evaluating rapid detection of candidemia using the T2Candida panel by T2 Biosystems has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidemia

Drugs mentioned

• T2Candida Panel

Snippet

Sponsor: T2 Biosystems | Conditions: Candidemia | Status: COMPLETED